Revance Therapeutics RVNC
$3.65
+0.01
(0.27%)
Valuation
- Market cap
- 381,023,000
- Revenue TTM
- $234,040,000
- Net income TTM
- $-323,990,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -138.43%
- Debt to equity
- -0.13
Trading
- Volume
- 4,123,100
- Avg volume
- 3,110,214
- Day's range
- $3.65 – $3.66
- Shares out
- 104,390,000
- Stochastic %K
- 47%
- Beta
- 0.90
- Analysts
- Sell
- Price target
- $8.00
Latest news
No headlines yet.
